In partnership with Transitions Optical, Johnson & Johnson Vision has developed a light-adaptive version of their best-selling Acuvue Oasys contact lenses capable of preventing harmful blue light and UV rays from entering the eye. Johnson & Johnson is the first company to secure US Food and Drug Administration (FDA) clearance of the contact lenses, which can be used to correct the vision of patients who are nearsighted, farsighted or have astigmatism.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,